Skip to contentP
Phathom Pharmaceuticals, Inc.
P
PHATPhathom Pharmaceuticals, Inc. Q1 2023 · 10-Q
Revenue$0.00$0.00no prior Q1 2022 on file Net Income-$37.81M-$37.81MN/M vs Q1 2022 EPS Diluted-$0.89-$0.89N/M vs Q1 2022 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
Operating Cash Flow-$39,669,000N/M Free Cash Flowderived-$39,883,000N/M ended Mar 31, 2023 · filed May 10, 2023 · 40 d after period end